ALLARITY THERAPEUTICS INC (ALLR) Stock Earnings Estimates

NASDAQ:ALLR • US0167445008

0.8451 USD
0 (-0.02%)
At close: Feb 13, 2026
0.87 USD
+0.02 (+2.95%)
After Hours: 2/13/2026, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
ALLR revenue by date.ALLR revenue by date.
120KN/A
-100.00%		N/A8.758M
EBITDA
YoY % growth
ALLR ebitda by date.ALLR ebitda by date.
-10.066MN/A
17.81%		N/A
-219.71%		N/A
36.36%		N/A
-1.54%		N/AN/AN/AN/A
EBIT
YoY % growth
ALLR ebit by date.ALLR ebit by date.
-10.117MN/A
17.77%		N/A
-219.22%		-32.165M
36.39%		-17.045M
-1.40%		-24.085M
-40.61%		-13.451M
44.15%		-15.912M
-18.30%		-16.64M
-4.58%
Operating Margin
ALLR operating margin by date.ALLR operating margin by date.
-8,430.83%N/AN/AN/AN/AN/AN/AN/A-190.00%
EPS
YoY % growth
ALLR eps by date.ALLR eps by date.
N/AN/AN/A-1,860,969.60-125,967.96
93.35%		-79.68
99.94%		-0.81
98.99%		-0.99
-22.78%		-25.70
-2,497.94%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.22
97.31%		-0.24-0.24
-63.20%		-0.24
-28.84%		-0.24
-9.09%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-3.57M
51.21%		-3.978M
-31.03%		-3.978M
3.75%		-3.978M
-57.98%		-3.978M
-11.43%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth		 -0.19
97.54%		-0.230.0419.01%
Q2 2025
Q2Q % growth		 -0.15
95.45%		-0.210.0629.97%
Q4 2024
Q2Q % growth
96.76%		-8.35%
Q3 2024
Q2Q % growth		 -7.71
99.43%		-8.690.9811.28%
Q2 2024
Q2Q % growth		 -3.30
99.98%		-8.785.4862.42%
Q1 2024
Q2Q % growth		 -664.20
99.38%		-53.86-610.34-1,133.29%
Q4 2023
Q2Q % growth		 -258.00
99.87%		-153.00-105.00-68.63%
Q3 2023
Q2Q % growth		 -1,344.00
99.76%		-5,000.043,656.0473.12%
Q2 2023
Q2Q % growth		 -15,768.00
96.39%		-6,848.28-8,919.72-130.25%
Q1 2023
Q2Q % growth		 -106,320.00 -192,877.9286,557.9244.88%
Q4 2022
Q2Q % growth		 -193,200.00 -357,285.60164,085.6045.93%
Q3 2022
Q2Q % growth		 -571,200.00 -218,484.00-352,716.00-161.44%
Q2 2022
Q2Q % growth		 -436,800.00 -359,856.00-76,944.00-21.38%
ALLR Yearly EPS VS EstimatesALLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 -500K -1M -1.5M
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
ALLR Yearly Revenue VS EstimatesALLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2027 2M 4M 6M 8M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS4.35% -4.76% 0% 0%
RevenueN/A N/A N/A N/A